Search Results for "1"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for 1. Results 941 to 950 of 2733 total matches.
Ceritinib (Zykadia) for Non-Small Cell Lung Cancer
The Medical Letter on Drugs and Therapeutics • Jul 21, 2014 (Issue 1447)
-positive metastatic NSCLC; crizotinib was the
first.1 Translocations of the ALK gene are found in
about 5 ...
Ceritinib (Zykadia – Novartis), an oral tyrosine
kinase inhibitor, has received accelerated approval
from the FDA for treatment of patients with anaplastic
lymphoma kinase (ALK)-positive metastatic
non-small cell lung cancer (NSCLC) who have
progressed on or are intolerant to crizotinib (Xalkori).
It is the second tyrosine kinase inhibitor to be approved
for ALK-positive metastatic NSCLC; crizotinib was the
first. Translocations of the ALK gene are found in
about 5% of lung cancers; they occur predominantly
in nonsmokers with adenocarcinoma.
Drugs for Hypertriglyceridemia
The Medical Letter on Drugs and Therapeutics • Mar 04, 2013 (Issue 1411)
triglyceride levels and should be tried first.1-3
TRIGLYCERIDE LEVELS AND RISK — Mildly (150-
200 mg/dL ...
Fibrates, niacin and fish oil are promoted for treatment
of hypertriglyceridemia. HMG-CoA reductase inhibitors
(statins) can lower elevated serum concentrations of
triglycerides, but less so than fibrates, niacins or fish oil.
Lifestyle changes such as weight reduction, exercise
and decreasing alcohol intake can also lower serum
triglyceride levels and should be tried first.
Enlicitide (Lipfendra) – An Oral PCSK9 Inhibitor for LDL-Cholesterol Lowering
The Medical Letter on Drugs and Therapeutics • Aug 31, 2026 (Issue 1762)
(Leqvio) are
injected subcutaneously.1 Lipfendra was approved under the
Commissioner’s National Priority ...
Enlicitide (Lipfendra – Merck), an oral proprotein convertase
subtilisin-kexin type 9 (PCSK9) inhibitor, has been approved
by the FDA to reduce low-density lipoprotein cholesterol
(LDL-C) in adults with hypercholesterolemia, including
heterozygous familial hypercholesterolemia (HeFH). It is the
first oral PCSK9 inhibitor to be approved in the US; the other
FDA-approved PCSK9 inhibitors (alirocumab [Praluent],
evolocumab [Repatha], and lerodalcibep [Lerochol]) and the
PCSK9-directed small interfering RNA inclisiran (Leqvio) are
injected subcutaneously. Lipfendra was approved under...
Med Lett Drugs Ther. 2026 Aug 31;68(1762):137-9 doi:10.58347/tml.2026.1762a | Show Introduction Hide Introduction
Chemotherapy for Esophageal, Gastric and Colorectal Cancers
Treatment Guidelines from The Medical Letter • Aug 01, 2006 (Issue 48)
is similar to that with surgery alone.
1
Prospective clinical trials have found that chemotherapy, usually ...
A variety of cancer chemotherapy drugs are used, mostly in combination, for treatment of locally advanced and metastatic esophageal, gastric and colorectal cancers. The mechanism of action, indications and adverse effects of some of these drugs are discussed in thei article.
IV Meloxicam (Anjeso) for Pain
The Medical Letter on Drugs and Therapeutics • Jun 29, 2020 (Issue 1601)
in efficacy and safety to other NSAIDs.1 It has COX-2
selectivity in vitro, which decreases at higher ...
The FDA has approved Anjeso (Baudax Bio), an IV
formulation of the nonsteroidal anti-inflammatory
drug (NSAID) meloxicam, for once-daily treatment
of moderate to severe pain in adults. Oral meloxicam
(Mobic, and others), which is only indicated
for treatment of chronic pain associated with
osteoarthritis or rheumatoid arthritis, has been
available for 20 years. IV formulations of ketorolac,
ibuprofen (Caldolor), and acetaminophen (Ofirmev)
are also available for treatment of pain.
Rezafungin (Rezzayo) for Invasive Candida Infections
The Medical Letter on Drugs and Therapeutics • Jun 24, 2024 (Issue 1705)
,
33% to amphotericin B, and 1% to echinocandins.1
STANDARD TREATMENT ― In patients with
candidemia ...
The FDA has approved rezafungin (Rezzayo – Cidara/Melinta), an intravenous echinocandin antifungal, for
once-weekly treatment of candidemia and invasive
candidiasis (IC) in adults with limited or no alternative
options. It is the first new drug to become available
in the US in more than 15 years for treatment of
systemic Candida infections.
Med Lett Drugs Ther. 2024 Jun 24;66(1705):101-4 doi:10.58347/tml.2024.1705d | Show Introduction Hide Introduction
Pharmaceutical Drug Overdose
Treatment Guidelines from The Medical Letter • Sep 01, 2006 (Issue 49)
, irritability/hyperactivity, fever,
sweating and aspiration pneumonitis.
1
Gastric lavage through a large ...
Every pharmaceutical drug is a dose-dependent poison. This article describes the clinical presentation and treatment of some dangerous overdoses commonly reported in adults.
In Brief: Phentermine (Lomaira) for Weight Loss
The Medical Letter on Drugs and Therapeutics • Dec 05, 2016 (Issue 1509)
with
topiramate for years.1
Table 1. Phentermine Products
Usual
Drug Formulations Dosage Cost1
Phentermine2 ...
The FDA has approved Lomaira (KVK Tech), an 8-mg tablet formulation of phentermine that can be taken up to three times daily before meals, as an adjunct to lifestyle modifications for weight loss. It is only approved for short-term use (a few weeks) in adults with a body mass index (BMI) ≥30 kg/m2, or with a BMI ≥27 kg/m2 in addition to a weight-related comorbidity such as hypertension, dyslipidemia, or diabetes. Phentermine has been available alone and in combination with topiramate for years.1Lomaira was approved by the FDA under an abbreviated new drug application (ANDA) and is...
COVID Update: Bivalent Vaccine Booster Doses Authorized for Children ≥5 Years Old (online only)
The Medical Letter on Drugs and Therapeutics • Oct 17, 2022 (Issue 1661)
(Pfizer) or 6 years old (Moderna).1
The bivalent Pfizer vaccine had previously been
authorized for use ...
The FDA has expanded its Emergency Use
Authorizations (EUAs) for the COVID-19 vaccines
manufactured by Pfizer/BioNTech (Comirnaty) and
Moderna (Spikevax) to permit use of the bivalent
formulations of these products (containing mRNA
from the original and BA.4/5 Omicron strains of
SARS-CoV-2) as a booster dose in children as young
as 5 years old (Pfizer) or 6 years old (Moderna).
The bivalent Pfizer vaccine had previously been
authorized for use in persons ≥12 years old and the
bivalent Moderna vaccine in persons ≥18 years old. Bivalent vaccines are not authorized for...
In Brief: Oral Minoxidil for Hair Loss
The Medical Letter on Drugs and Therapeutics • Dec 26, 2022 (Issue 1666)
IN BRIEF
Oral Minoxidil for Hair Loss
1. A Adil and M Godwin. The effectiveness of treatments ...
Topical minoxidil (Rogaine, and others), which is
available over the counter, has been used for treatment
of hair loss in men and women for more than 30 years.
Recently published trials suggest that off-label use of
a low dose of oral minoxidil may also be effective.
